LaShann Moutique DeArcy Hall

LaShann Moutique DeArcy Hall

Ask VT AI
View News Summary
  • FDA drug regulator resigns amid bribery and defamation allegations, denies wrongdoing and claims retaliation for criticizing agency officials.
  • Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
  • Bitcoin and altcoins plunge, triggering over $1 billion in liquidations, as global liquidity growth decelerates and analysts remain divided on the market's outlook.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • FDA drug regulator resigns amid bribery and defamation allegations, denies wrongdoing and claims retaliation for criticizing agency officials.
  • Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
  • Bitcoin and altcoins plunge, triggering over $1 billion in liquidations, as global liquidity growth decelerates and analysts remain divided on the market's outlook.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from LaShann Moutique DeArcy Hall